ABBV
AbbVie Inc
$250.60
2.06 (0.83%) Today
0.27 (0.11%) After-hours
— up— down
Market Cap
$439.59B+24.5%
Revenue (TTM)
$64.23B+10.4%
Net Income (TTM)
$6.29B+67.6%
EPS (TTM)
3.56+67.6%
Shares Out
1.77B
1.77BP/E Ratio
69.67
69.67Forward P/E
16.77
16.77Dividend
$6.60 (2.78%)
$6.60 (2.78%)Ex-Dividend Date
Jul 15, 2026
Jul 15, 2026Open
$252.94
$252.94Previous Close
$248.76
$248.76Day Range
$249.35 – $255.30
$249.35 – $255.3052-Week Range
$190.75 – $267.47
$190.75 – $267.47Beta
0.21
0.21Volume
3.47M
3.47MAvg Volume
6.69M
6.69MAnalyst Rating
Buy
BuyExchange
NEW YORK STOCK EXCHANGE, INC.
NEW YORK STOCK EXCHANGE, INC.About ABBV
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
Related
News
N/AN/AN/AN/AN/A
The Sharpest Exchanges From ABBV's Earnings Call
Yahoo · 5h ago
Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
Yahoo · 7h ago
Wolfe Research Upgrades AbbVie to Outperform, Announces $300 Price Target
Benzinga · 7h ago
Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More
Yahoo · 9h ago
How ABBV Stock Moved Away From Its Peer Group
Yahoo · 1d ago